- Home
- ASND vs ESS Comparison
ASND vs ESS Comparison
Compare ASND & ESS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | ESS |
|---|---|---|
| Founded | 2006 | 1971 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 15.5B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ASND | ESS |
|---|---|---|
| Price | $228.00 | $247.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 16 |
| Target Price | $279.50 | ★ $282.30 |
| AVG Volume (30 Days) | ★ 440.9K | 429.9K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 10.40 |
| Revenue | N/A | ★ $1,887,345,000.00 |
| Revenue This Year | $97.60 | $1.99 |
| Revenue Next Year | $43.64 | $3.39 |
| P/E Ratio | ★ N/A | $23.80 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $124.06 | $238.46 |
| 52 Week High | $248.60 | $294.09 |
Technical Indicators
Market Signals| Indicator | ASND | ESS |
|---|---|---|
| Relative Strength Index (RSI) | 53.82 | 49.24 |
| Support Level | $190.49 | N/A |
| Resistance Level | $233.88 | $263.53 |
| Average True Range (ATR) | 8.02 | 4.87 |
| MACD | 0.34 | 0.13 |
| Stochastic Oscillator | 66.05 | 55.81 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 259 apartment communities with over 63,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.